JEFFREY HARRIS: Open Payments
NPI 1396723342 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 41 payments from 21 companies in 2025. Trend: 2023 $1,512 · 2024 $1,353 · 2025 $1,205
Food & beverage: $1,030Education: $175
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $265 |
| Daiichi Sankyo Inc. | 5 | $206 |
| ABBVIE INC. | 5 | $112 |
| SANOFI-AVENTIS U.S. LLC | 1 | $75 |
| PFIZER INC. | 3 | $61 |
| Stemline Therapeutics Inc. | 2 | $59 |
| GENZYME CORPORATION | 2 | $47 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Lilly USA, LLC | 2 | $37 |
Products named: Enhertu, SARCLISA, LYNPARZA, EPKINLY, Orserdu, KEYTRUDA, IBRANCE, VERZENIO.
Industry payments across GA — which companies pay providers there.
